Fundraising Fox

Apeiron Therapeutics

Burlingame, US · 17 employees on LinkedIn · 2 known investors

Apeiron Therapeutics is a biotech company developing small-molecule therapeutics with a focus on immuno-oncology and oncology drug discovery. The company operates across the Chinese and global healthcare markets, spanning target identification, medicinal chemistry, and clinical development.

AI & Machine LearningBiotechDeep TechHealthtech

Founders & leadership

ML
Mingxi LiinCEO
FAFred Aswad
Fred AswadinChief Scientific Officer

Investors · 2

Sofinnova VenturesMenlo Park · $100K – $15M
Panacea VenturereportedSingapore

In the news

Apeiron Closes $17.5 Million Series A and Launches Strategic Partnerships — Apeiron Therapeuticsapeiron-bio.com · Mar 2022GT Apeiron Therapeutics Raises $27M in Funding - FinSMEsfinsmes.com · Jun 2019

Frequently asked questions

What does Apeiron Therapeutics do?
Apeiron Therapeutics is a biotech company developing small-molecule therapeutics with a focus on immuno-oncology and oncology drug discovery. The company operates across the Chinese and global healthcare markets, spanning target identification, medicinal chemistry, and clinical development.
Who are Apeiron Therapeutics's investors?
Apeiron Therapeutics's investors include Sofinnova Ventures, Panacea Venture.
Where is Apeiron Therapeutics headquartered?
Apeiron Therapeutics is headquartered in Burlingame, US.